Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
170 participants
INTERVENTIONAL
2019-04-01
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome
NCT02460380
Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)
NCT00907153
Impact of Vitamin D Supplementation on Cardiometabolic Status and Androgen Profile in Polycystic Ovary Syndrome
NCT04117750
Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
NCT02865187
Effect of Vitamin D on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome
NCT02513381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D group
These patients will receive 6000IU daily for 8 weeks then 2000IU maintenance till pregnancy or end of study
Vitamin D
receive 6000iu daily for 8 weeks
Placebo group
These group will receive placebo for the same periods of study group
Placebo Oral Tablet
placebo for the same period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
receive 6000iu daily for 8 weeks
Placebo Oral Tablet
placebo for the same period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infertile
* Vitamin D deficient
Exclusion Criteria
* Non PCOS patients
* Obese patients
* Previous ovarian surgery
* Previous oophrectomy of one ovary
20 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman S Dawood, MD
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ayman Shehata Dawood
Tanta, Algharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCOvit-D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.